Dual therapy for Helicobacter pylori infection
Dual therapy for Helicobacter pylori infection
About this item
Full title
Author / Creator
Duan, Miao , Liu, Jing and Zuo, Xiuli
Publisher
Hagerstown, MD: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
Hagerstown, MD: Lippincott Williams & Wilkins
More information
Scope and Contents
Contents
AbstractBismuth-containing quadruple therapy (BQT) has long been recommended for Helicobacter pylori (H. pylori) eradication in China. Meanwhile, in the latest national consensus in China, dual therapy (DT) comprising an acid suppressor and amoxicillin has also been recommended. In recent years, the eradication rate of H. pylori has reached >90% us...
Alternative Titles
Full title
Dual therapy for Helicobacter pylori infection
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_wolterskluwer_health_10_1097_CM9_0000000000002565
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_wolterskluwer_health_10_1097_CM9_0000000000002565
Other Identifiers
ISSN
0366-6999
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000002565
